ArticleHeliyon2021
Neurological complications associated with coronavirus disease-2019 (COVID-19): MRI features.
Article in Heliyon, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.
- Topographical Distribution of Neuroanatomical Abnormalities Following COVID-19 Invasion : A Systematic Literature Review.Clinical neuroradiology · 2024Pooled it
- Brain MRI findings in neurologically symptomatic COVID-19 patients: a systematic review and meta-analysis.Journal of neurology · 2023Pooled it
- Review
- Brain Imaging Changes in Patients Recovered From COVID-19: A Narrative Review.Frontiers in neuroscience · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) is an RNA virus, which is a strain of Severe Acute Respiratory Syndrome-related CoronaVirus (SARSr-CoV), of Coronavirus family. On 31 December 2019, a cluster of cases of unknown pneumonia in Wuhan-China was reported to the World Health Organization (WHO) that subsequently spreading as coronavirus disease 2019-(COVID-19) pandemic worldwide. On 12 January 2020, novel SARS-COV-2 was declared the cause of COVID-19 from the initial analysis of the virus genetic sequences obtained from lower respiratory tract specimen of 41 patients admitted to a designated hospital in Wuhan. The classical COVID-19 presentation is respiratory symptoms. Neuroradiological findings were reported. Our aim is to document neurological complication of COVID-19. We observed confirmed 23 COVID-19 patients presented with severe neurological symptoms. Brain-MRI showed predominately; cerebrovascular thromboembolism-related acute infarcts, autoimmune-meningoencephalitis, Acute disseminated encephalomyelitis (ADEM)-like white matter lesions.
conclusionDifferent neurological presentations are associated with COVID-19, necessitating further studies to clarify the mechanism of its CNS involvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.